FEops Elects Rob Michiels As Chairman

GENT, Belgium--(BUSINESS WIRE)--FEops, which is developing “future-generation planning technology for transcatheter valve therapies”, today announced that it has elected Rob Michiels to serve as Chairman of the Board of Directors, effectively immediately. Until September 2015, Michiels was Chief Executive Officer at CardiAQ Valve Technologies, the Transcatheter Mitral Valve Replacement (TMVR) company, which was acquired by Edwards Lifesciences.